1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6CDFB73088A9D887500258958004A8CC6
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/medicals-road-map-for-social-media-success
18
19
203.92.91.54
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




» Products & Services » » Medical Affairs » Medical Affairs Excellence

Medical’s Road Map for Social Media Success

ID: POP-358


Features:

20 Info Graphics

108 Data Graphics

1370+ Metrics

12 Narratives


Pages: 137


Published: 2023


Delivery Format: Shipped


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
More than half of the world uses social media, including health care providers (HCPs), thought leaders, and digital opinion leaders. Innovative Medical Affairs groups thus enjoy a huge opportunity to reach, nurture, and engage with key stakeholders.

Best Practices, LLC undertook benchmarking research to develop a roadmap for Medical Affairs’ social media success. This report examines current trends and success factors in harnessing social media for effectively educating the market. Our report delivers benchmarks and critical insights around Medical Social structure, activities, content sharing policies, stakeholder collaborations, content review committees, omnichannel integration, and key performance indicators.

Video Brief:


Industries Profiled:
Pharmaceutical; Biotech; Medical Device; Manufacturing; Consumer Products; Diagnostic; Communications; Medical; Biopharmaceutical; Health Care; Consulting


Companies Profiled:
AbbVie; Avidity Biosciences; AstraZeneca; Baxter Healthcare; Bayer; BIAL; Boehringer Ingelheim; Boston Scientific; Complete HealthVizion | An IPG Health Company; Dompé; DURECT Corporation; Eisai; Elevation Oncology; EMD Serono; Ethicon Endo-Surgery Inc.; Gossamer Bio; Grifols; Hoya Vision Care; Janssen; LEO Pharma; MedVal Scientific Information Services; Merck KGaA; Merck Sharp & Dohme; Merz Pharma; Merz Aesthetics; Myovant Sciences; Nobel Biocare; Novartis; Novartis Oncology; Novo Nordisk; PRECISIONscientia; Servier; Supernus; Takeda Pharmaceuticals; Teva Pharmaceutical Industries Ltd; UCB Pharma

Study Snapshot

Best Practices, LLC engaged 48 Medical leaders from 36 biopharma companies in this benchmarking research using an integrated framework to examine current trends and future directions to construct the roadmap for social media success under Medical Affairs auspices across 21 therapeutic areas.

Key topics covered in this report include:

  • Social Media Structure and Management
  • Social Media Activities
  • Social Media Omnichannel Integration
  • Social Media Message Characteristics and Performance Measurement
  • Social Media Innovation in Medical
  • Social Media Content and Sharing Trends

Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.


  • Impact of Structure on Social Function: It appears groups that prioritize social media activity -- through structure, clear roles and ownership, and growth of social media compliance teams in Medical -- evidence greater social collaboration, account innovation, and broad-reaching activities.
  • Channel Agility: Social channels are used for different purposes to reach diverse stakeholders with different content. Clinical trials, new science, government affairs, PAG’s, and corporate scientific branding are innovation fronts.
  • Social Listening and Data Sharing: Oncology and Immunology groups excel at social media listening, rare disease excels at raising awareness of clinical data against segments.

Table of Contents

Sr. No.
Topic
Slide No.
I.
Section 1: Executive SummaryPg. 3-16
II.
Section 2: Social Media StructurePg. 17-38
III.
Section 3: Social Media ActivitiesPg. 39-78
IV.
Section 4: Social Media Omnichannel IntegrationPg. 79-92
V.
Section 5: Social Media Message Characteristics and Performance MeasurementPg. 93-114
VI.
Section 6: Analysis of the Geographic SegmentPg. 115-136
VII.
About Best Practices, LLCPg. 137

    List of Charts & Exhibits

    I. Social Media Structure

    • Social media account quantity of benchmark organizations – Total benchmark class
    • Social media account quantity of benchmark organizations – Oncology segment vs. others
    • Social media account quantity of benchmark organizations – Immunology segment vs. others
    • Social media account quantity of benchmark organizations – Rare disease segment vs. others
    • Range of multiple social media accounts – Total benchmark class
    • Separation of benchmark organizations’ social media accounts – Total benchmark class
    • Separation of benchmark organizations’ social media accounts – Geography segments
    • Separation of benchmark organizations’ social media accounts – Oncology segment vs. others
    • Separation of benchmark organizations’ social media accounts – Immunology segment vs. others
    • Separation of benchmark organizations’ social media accounts – Rare disease segment vs. others
    • Share of social media account ownership – Total benchmark class
    • Involvement of Medical Affairs in social media initiatives at benchmark organizations – Total benchmark class
    • Involvement of Medical Affairs in social media initiatives at benchmark organizations – Geography segments
    • Involvement of Medical Affairs in social media initiatives at benchmark organizations – Oncology segment vs. others
    • Involvement of Medical Affairs in social media initiatives at benchmark organizations – Immunology segment vs. others
    • Involvement of Medical Affairs in social media initiatives at benchmark organizations – Rare disease segment vs. others
    • Medical Affairs’ vendor utilization for social media activities – Total benchmark class
    • Medical Affairs’ vendor utilization for social media activities – Geography segments

    II. Social Media Activities

    • Most utilized social media platforms by Medical Affairs groups – Total benchmark class
    • Most utilized social media platforms by Medical Affairs groups – Oncology segment vs. others
    • Most utilized social media platforms by Medical Affairs groups – Immunology segment vs. others
    • Most utilized social media platforms by Medical Affairs groups – Rare disease segment vs. others
    • Target audiences for Medical’s social media activities – Total benchmark class
    • Target audiences for Medical’s social media activities – Medical leads social media initiatives segment
    • Target audiences for Medical’s social media activities – Geography segments
    • Target audiences for Medical’s social media activities – Oncology segment vs. others
    • Target audiences for Medical’s social media activities – Immunology segment vs. others
    • Target audiences for Medical’s social media activities – Rare disease segment vs. others
    • Goals for Medical Affairs group’s social media efforts – Total benchmark class
    • Goals for Medical Affairs group’s social media efforts – Social media compliance team segment
    • Goals for Medical Affairs group’s social media efforts – Medical leads social media initiatives segment
    • Goals for Medical Affairs group’s social media efforts – Geography segments
    • Goals for Medical Affairs group’s social media efforts – Oncology segment vs. others
    • Goals for Medical Affairs group’s social media efforts – Immunology segment vs. others
    • Goals for Medical Affairs group’s social media efforts – Rare disease segment vs. others
    • Proactive vs. reactive social media interactions over time – Total benchmark class
    • Proactive vs. reactive social media interactions over time – Medical leads social media initiatives segment
    • Proactive vs. reactive social media interactions over time – Social media compliance team segment
    • Proactive vs. reactive social media interactions over time – Oncology segment vs. others
    • Proactive vs. reactive social media interactions over time – Immunology segment vs. others
    • Effectiveness of social media platforms for conveying therapeutic/disease state information – Total benchmark class
    • Effectiveness of social media platforms for communicating on-label clinical study data for a new or expanded indication – Total benchmark class
    • Effectiveness of social media platforms for posting information on new scientific papers/abstracts – Total benchmark class
    • Effectiveness of social media platforms for posting information on new scientific papers/abstracts – Oncology segment vs. others
    • Effectiveness of social media platforms for posting information from KOLs/DOLs/thought leaders – Total benchmark class
    • Effectiveness of social media platforms for industry commentary – Total benchmark class
    • Effectiveness of social media platforms for community groups commentary – Total benchmark class
    • Effectiveness of therapeutic/disease state information in engaging each target audience – Total benchmark class
    • Effectiveness of communicating on-label clinical study data in engaging each target audience – Total benchmark class
    • Effectiveness of communicating clinical study data for a new or expanded indication in engaging each target audience – Total benchmark class
    • Effectiveness of posting information on new scientific papers/abstracts in engaging each target audience – Total benchmark class
    • Effectiveness of posts from KOLs/DOLs/thought leaders in engaging each target audience – Total benchmark class
    • Effectiveness of industry commentary in engaging each target audience – Total benchmark class
    • Effectiveness of commentary from community groups in engaging each target audience – Total benchmark class

    III. Social Media Omnichannel Integration

    • Organizational structure used by Medical Affairs to engage in omnichannel activities – Total benchmark class
    • Organizational structure used by Medical Affairs to engage in omnichannel activities – Oncology segment vs. others
    • Organizational structure used by Medical Affairs to engage in omnichannel activities – Immunology segment vs. others
    • Organizational structure used by Medical Affairs to engage in omnichannel activities – Rare disease segment vs. others
    • Platforms on which Medical conducts omnichannel activities for social media
    • Medical group’s strategy for handling misleading or non-compliant information on social media
    • Medical’s content sharing policies on social media – Total benchmark class
    • Medical’s content sharing policies on social media – Oncology segment vs. others
    • Medical’s content sharing policies on social media – Immunology segment vs. others
    • Medical’s content sharing policies on social media – Rare disease segment vs. others
    • Types of content re-shared from other (unaffiliated) accounts by Medical Affairs

    IV. Social Media Message Characteristics and Performance Measurement

    • Presence of committees for specifically reviewing social media content from a Medical compliance lens – Total benchmark class
    • Presence of committees for specifically reviewing social media content from a Medical compliance lens – Medical leads social media initiatives segment
    • Presence of committees for specifically reviewing social media content from a Medical compliance lens – Oncology segment vs. others
    • Presence of committees for specifically reviewing social media content from a Medical compliance lens – Immunology segment vs. others
    • Presence of committees for specifically reviewing social media content from a Medical compliance lens – Rare disease segment vs. others
    • Percentage of brand-oriented, molecule-oriented, and disease state-oriented social media posts
    • Percentage of Medical Affairs group’s social media posts which are primarily graphic, contain a mix of both graphics and text, and are primarily text – Total benchmark class
    • Percentage of Medical Affairs group’s social media posts which are primarily graphic, contain a mix of both graphics and text, and are primarily text – Oncology segment vs. others
    • Percentage of Medical Affairs group’s social media posts which are primarily graphic, contain a mix of both graphics and text, and are primarily text – Immunology segment vs. others
    • Percentage of Medical Affairs group’s social media posts which are primarily graphic, contain a mix of both graphics and text, and are primarily text – Rare disease segment vs. others
    • Effectiveness of each key performance indicator for measuring the success of Medical Affairs group’s social media engagements – Total benchmark class
    • Effectiveness of each key performance indicator for measuring the success of Medical Affairs group’s social media engagements – Oncology segment vs. others
    • Effectiveness of each key performance indicator for measuring the success of Medical Affairs group’s social media engagements – Immunology segment vs. others
    • Effectiveness of each key performance indicator for measuring the success of Medical Affairs group’s social media engagements – Rare disease segment vs. others
    • External stakeholders that contribute to the development of content for Medical Affairs group’s collaborative social media activities – Total benchmark class
    • External stakeholders that contribute to the development of content for Medical Affairs group’s collaborative social media activities – Medical leads social media initiatives segment
    • External stakeholders that contribute to the development of content for Medical Affairs group’s collaborative social media activities – Social media compliance team segment
    • External stakeholders that contribute to the development of content for Medical Affairs group’s collaborative social media activities – Oncology segment vs. others
    • External stakeholders that contribute to the development of content for Medical Affairs group’s collaborative social media activities – Rare disease segment vs. others
    • External stakeholders that contribute to the development of content for Medical Affairs group’s collaborative social media activities – Immunology segment vs. others

    V. Analysis of the Geographic Segment

    • Geographic span of responsibility of benchmark partners
    • Managing single vs. multiple social media account quantities – Global vs. US vs. Europe segment
    • Multiple accounts range – Global vs. US vs. Europe segment
    • Segmentation of social media accounts – Global vs. US vs. Europe segment
    • Influence of Medical Affairs on the organization’s social media initiatives – Global vs. US vs. Europe segment
    • Utilization of third-party vendors to support or drive social media activities – Global vs. US vs. Europe segment
    • Social media platforms utilized by Medical Affairs groups – Global vs. US vs. Europe segment
    • Geographic target audiences for Medical’s social media activities
    • Goals for Medical Affairs’ social media efforts – Global vs. US vs. Europe segment
    • Proactive vs. reactive social media interactions over time – Global vs. US vs. Europe segment
    • Proactive social media activities for Medical – Global vs. US vs. Europe segment
    • Social media audits in Medical Affairs – Global vs. US vs. Europe segment
    • Medical’s content re-sharing policies on social media – Global vs. US vs. Europe segment
    • Omnichannel social media structure – Global vs. US vs. Europe segment
    • Social media committees for Medical Legal review – Global vs. US vs. Europe segment
    • Medical Affairs group’s social media message orientation – Global vs. US vs. Europe segment
    • Medical Affairs group’s social media content mix – Global vs. US vs. Europe segment
    • Medical Affairs group’s external collaboration for social media content development – Global vs. US vs. Europe segment